The Clorox Company $CLX Shares Acquired by Canvas Wealth Advisors LLC

Canvas Wealth Advisors LLC raised its stake in shares of The Clorox Company (NYSE:CLX) by 18.6% during the 3rd quarter, Holdings Channel.com reports. The fund owned 111,481 shares of the company’s stock after acquiring an additional 17,455 shares during the period. Clorox accounts for about 1.2% of Canvas Wealth Advisors LLC’s portfolio, making the stock its 19th biggest position. Canvas Wealth Advisors LLC’s holdings in Clorox were worth $9,885,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of CLX. Pension & Wealth Management Advisors Inc. bought a new stake in shares of Clorox in the 3rd quarter worth $26,000. Ancora Advisors LLC bought a new position in shares of Clorox during the second quarter valued at about $28,000. Avalon Trust Co bought a new position in shares of Clorox during the second quarter valued at about $29,000. Markowski Investments purchased a new position in Clorox during the second quarter worth about $30,000. Finally, Barrett & Company Inc. boosted its holdings in Clorox by 86.0% during the third quarter. Barrett & Company Inc. now owns 372 shares of the company’s stock worth $30,000 after purchasing an additional 172 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Pierre Breber purchased 4,000 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The stock was bought at an average price of $100.06 per share, for a total transaction of $400,240.00. Following the purchase, the director directly owned 22,000 shares in the company, valued at approximately $2,201,320. This trade represents a 22.22% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.51% of the stock is currently owned by insiders.

Clorox Stock Performance

Shares of NYSE:CLX traded up $0.10 during midday trading on Friday, reaching $99.80. The company had a trading volume of 2,387,525 shares, compared to its average volume of 2,530,187. The stock has a market cap of $12.07 billion, a P/E ratio of 17.95, a P/E/G ratio of 3.00 and a beta of 0.59. The company’s 50 day moving average price is $87.71 and its 200 day moving average price is $99.67. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 2nd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.48. The business had revenue of $1.91 billion during the quarter, compared to the consensus estimate of $1.88 billion. Clorox had a net margin of 9.41% and a return on equity of 601.88%. The firm’s quarterly revenue was up 33.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.85 earnings per share. As a group, sell-side analysts anticipate that The Clorox Company will post 5.76 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 5.0%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox’s dividend payout ratio is currently 89.93%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. BNP Paribas Exane decreased their price objective on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research note on Monday, July 20th. The Goldman Sachs Group reissued a “sell” rating and set a $74.00 target price on shares of Clorox in a research report on Tuesday. Citigroup cut their target price on Clorox from $97.00 to $90.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 14th. UBS Group set a $88.00 target price on Clorox in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $95.00 target price on shares of Clorox in a report on Monday, October 19th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus target price of $93.79.

Clorox Profile

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.